NAVIFY® Mutation Profiler

The Power to Do More

A CE-IVD labelled clinical NGS reporting solution that can help labs accurately and efficiently interpret the clinical significance of mutations, empowering clinicians to deliver more personalized healthcare.

 

"Precision medicine requires precision in clinical interpretation and reporting. With NAVIFY Mutation Profiler*, our lab has access to the most clinically relevant and up-to-date information, drastically reducing our curation time. The intuitive software produces concise, actionable reports that accelerates our clinicians’ ability to deliver the best treatment options for our patients."

Dr. Markus Tiemann

Institut für Hämatopathologie Hamburg

© 2020 Roche Molecular Systems, Inc. NAVIFY is a trademark of Roche. All other product names and trademarks are the property of their respective owners.